1. Home
  2. PAYO vs NRIX Comparison

PAYO vs NRIX Comparison

Compare PAYO & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$4.70

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$15.79

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYO
NRIX
Founded
2005
2009
Country
United States
United States
Employees
2540
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PAYO
NRIX
Price
$4.70
$15.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$7.69
$30.50
AVG Volume (30 Days)
3.3M
691.1K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$7.15
N/A
Revenue Next Year
$10.28
$48.05
P/E Ratio
$30.36
N/A
Revenue Growth
N/A
99.31
52 Week Low
$4.08
$8.20
52 Week High
$7.67
$22.50

Technical Indicators

Market Signals
Indicator
PAYO
NRIX
Relative Strength Index (RSI) 38.88 43.21
Support Level $4.35 $15.22
Resistance Level $4.86 $16.71
Average True Range (ATR) 0.20 0.76
MACD -0.04 -0.13
Stochastic Oscillator 0.00 10.77

Price Performance

Historical Comparison
PAYO
NRIX

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: